博来霉素在人体中的药代动力学。I. 静脉给药。 - Suppr

Bleomycin pharmacokinetics in man. I. Intravenous administration.

作者信息

Alberts D S, Chen H S, Liu R, Himmelstein K J, Mayersohn M, Perrier D, Gross J, Moon T, Broughton A, Salmon S E

出版信息

Cancer Chemother Pharmacol. 1978;1(3):177-81. doi: 10.1007/BF00253118.

DOI:10.1007/BF00253118

PMID:86392

Abstract

摘要

相似文献

Bleomycin pharmacokinetics in man. I. Intravenous administration.

Cancer Chemother Pharmacol. 1978;1(3):177-81. doi: 10.1007/BF00253118.

Bleomycin pharmacokinetics in man. II. Intracavitary administration.

Cancer Chemother Pharmacol. 1979;2(2):127-32. doi: 10.1007/BF00254085.

Pharmacokinetics of bleomycin after im administration in man.

Cancer Treat Rep. 1981 May-Jun;65(5-6):485-9.

Effects of variations in renal function on the clinical pharmacology of bleomycin administered as an iv bolus.

Cancer Treat Rep. 1977 Dec;61(9):1631-6.

[Studies on the administration of bleomycin in a nude mouse model of squamous cell carcinoma of the mouth. 1. 57Co-bleomycin pharmacokinetics after intratumor and intravenous administration].

Radiobiol Radiother (Berl). 1984;25(1):143-52.

[57Co-bleomycin kinetics after local and systemic administration].

Dtsch Zahnarztl Z. 1980 Jan;35(1):96-8.

Bleomycin disposition in children with cancer.

Clin Pharmacol Ther. 1983 May;33(5):668-73. doi: 10.1038/clpt.1983.91.

Subcutaneous infusion of bleomycin--a practical alternative to intravenous infusion.

J Clin Oncol. 1987 Apr;5(4):648-50. doi: 10.1200/JCO.1987.5.4.648.

The pharmacokinetics of bleomycin in man.

J Clin Pharmacol. 1978 Jul;18(7):346-52. doi: 10.1002/j.1552-4604.1978.tb01604.x.

A clinical trial of intravenous bleomycin in the treatment of brain tumors.

Int J Clin Pharmacol Biopharm. 1975 Dec;12(4):419-26.

引用本文的文献

The Interaction of the Metallo-Glycopeptide Anti-Tumour Drug Bleomycin with DNA.

Int J Mol Sci. 2018 May 4;19(5):1372. doi: 10.3390/ijms19051372.

Safety and efficacy of bleomycin/pingyangmycin-containing chemotherapy regimens for malignant germ cell tumor patients in the female genital system.

Oncotarget. 2017 Feb 28;8(9):15952-15960. doi: 10.18632/oncotarget.15021.

Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage.

PLoS One. 2015 Jan 15;10(1):e0115372. doi: 10.1371/journal.pone.0115372. eCollection 2015.

Tumor size and effectiveness of electrochemotherapy.

Radiol Oncol. 2013 Mar;47(1):32-41. doi: 10.2478/raon-2013-0002. Epub 2013 Feb 1.

Accurate measurement of individual glomerular filtration rate in cancer patients: an ongoing challenge.

J Cancer Res Clin Oncol. 2005 Sep;131(9):559-67. doi: 10.1007/s00432-005-0679-7. Epub 2005 Oct 20.

Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.

Cancer Chemother Pharmacol. 1981;6(3):253-64. doi: 10.1007/BF00256978.

Antipyrine metabolism in patients with disseminated testicular cancer and the influence of cytostatic treatment.

Cancer Chemother Pharmacol. 1984;13(3):181-5. doi: 10.1007/BF00269025.

Clinical pharmacokinetics of commonly used anticancer drugs.

Clin Pharmacokinet. 1983 May-Jun;8(3):202-32. doi: 10.2165/00003088-198308030-00002.

Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administration.

Br J Cancer. 1980 Apr;41(4):644-7. doi: 10.1038/bjc.1980.110.

In vitro evaluation of anticancer drugs in relation to development of drug resistance in the human tumor clonogenic assay.

Cancer Chemother Pharmacol. 1985;15(3):208-13. doi: 10.1007/BF00263887.

本文引用的文献

New antibiotics, bleomycin A and B.

J Antibiot (Tokyo). 1966 Sep;19(5):200-9.

Statistical estimations in pharmacokinetics.

J Pharmacokinet Biopharm. 1974 Apr;2(2):123-48. doi: 10.1007/BF01061504.

Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance.

Cancer. 1974 May;33(5):1230-8. doi: 10.1002/1097-0142(197405)33:5<1230::aid-cncr2820330507>3.0.co;2-c.

Letter: Chemistry of bleomycin. XI. The structures of the terminal amines.

J Antibiot (Tokyo). 1973 Jul;26(7):398-9. doi: 10.7164/antibiotics.26.398.

Letter: New components of bleomycin.

J Antibiot (Tokyo). 1973 Jul;26(7):396-7. doi: 10.7164/antibiotics.26.396.

A clinical review of bleomycin--a new antineoplastic agent.

Cancer. 1973 Apr;31(4):903-14. doi: 10.1002/1097-0142(197304)31:4<903::aid-cncr2820310422>3.0.co;2-n.

Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients.

Ann Intern Med. 1972 Dec;77(6):861-70. doi: 10.7326/0003-4819-77-6-861.

CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.

J Pharm Sci. 1976 Jul;65(7):1006-10. doi: 10.1002/jps.2600650713.

Effects of variations in renal function on the clinical pharmacology of bleomycin administered as an iv bolus.

Cancer Treat Rep. 1977 Dec;61(9):1631-6.

Specificity of antisera produced against bleomycin.

Cancer Treat Rep. 1977 Nov;61(8):1509-12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Bleomycin pharmacokinetics in man. I. Intravenous administration.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献